1. Home
  2. ONVO vs CISS Comparison

ONVO vs CISS Comparison

Compare ONVO & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONVO
  • CISS
  • Stock Information
  • Founded
  • ONVO 2007
  • CISS 2022
  • Country
  • ONVO United States
  • CISS Greece
  • Employees
  • ONVO N/A
  • CISS N/A
  • Industry
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • CISS Marine Transportation
  • Sector
  • ONVO Health Care
  • CISS Consumer Discretionary
  • Exchange
  • ONVO Nasdaq
  • CISS Nasdaq
  • Market Cap
  • ONVO 6.5M
  • CISS 5.3M
  • IPO Year
  • ONVO N/A
  • CISS N/A
  • Fundamental
  • Price
  • ONVO $0.39
  • CISS $1.23
  • Analyst Decision
  • ONVO
  • CISS
  • Analyst Count
  • ONVO 0
  • CISS 0
  • Target Price
  • ONVO N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • ONVO 243.5K
  • CISS 168.3K
  • Earning Date
  • ONVO 02-06-2025
  • CISS 11-18-2024
  • Dividend Yield
  • ONVO N/A
  • CISS N/A
  • EPS Growth
  • ONVO N/A
  • CISS N/A
  • EPS
  • ONVO N/A
  • CISS N/A
  • Revenue
  • ONVO $103,000.00
  • CISS $46,661,732.00
  • Revenue This Year
  • ONVO $59.08
  • CISS N/A
  • Revenue Next Year
  • ONVO $18.24
  • CISS N/A
  • P/E Ratio
  • ONVO N/A
  • CISS N/A
  • Revenue Growth
  • ONVO N/A
  • CISS 491.48
  • 52 Week Low
  • ONVO $0.32
  • CISS $1.17
  • 52 Week High
  • ONVO $1.74
  • CISS $49.25
  • Technical
  • Relative Strength Index (RSI)
  • ONVO 47.81
  • CISS 33.66
  • Support Level
  • ONVO $0.34
  • CISS $1.24
  • Resistance Level
  • ONVO $0.51
  • CISS $1.36
  • Average True Range (ATR)
  • ONVO 0.06
  • CISS 0.14
  • MACD
  • ONVO -0.00
  • CISS 0.01
  • Stochastic Oscillator
  • ONVO 30.00
  • CISS 8.00

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: